Search
Dr James Good

Dr James Good

Clinical oncology 06104512

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

James Good is a leading Birmingham-based cancer specialist. After training in Cambridge and London, he has established a cutting edge practice focused on gastro-intestinal and head/neck cancer. James works closely with top surgeons and key medical specialties to develop an integrated treatment plan that achieves the best possible outcomes, whilst ensuring that wellbeing is made a key priority. James' patients tell him that they value his warm, pragmatic and open approach.

James believes that everyone with cancer should have access to innovative and evidence-based treatment. He is a national expert in the treatment of liver and pancreatic tumours with advanced radiotherapy and has delivered a number of clinical trials investigating immunotherapy and novel drug/radiotherapy combinations.

Since 2018, James has been Clinical Director of Stereotactic Radiotherapy for GenesisCare, the UK's largest provider of private radiotherapy. He has lead the implementation of MRI-guided radiotherapy in Oxford and London - a technique that offers a step-change in accurate tumour targeting.

Areas of interest

Bowel cancer; Cholangiocarcinoma; Colon cancer; Liver cancer; Liver metastases; Oral cancer; Pancreatic cancer; Rectal cancer; Salivary gland cancer; Sinus cancer; Throat cancer; Thyroid cancer; Tongue cancer; Tonsil cancer; Chemotherapy; CyberKnife; Immunotherapy; Personalised medicine; Radiotherapy; SABR; SBRT; SIRT; MRIdian

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • A1080

    Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)

    Spire Little Aston Hospital (1-5)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

    Priory Hospital (The) (5-50) Spire Little Aston Hospital (5-50)

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

    Spire Little Aston Hospital (5-50)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Spire Little Aston Hospital (5-50)

  • A1070

    Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (5-50)

  • X0001

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)

    GenesisCare, Birmingham (5-50)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

    GenesisCare, Birmingham (1-5)

  • Show All (10 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.